Product Information
LURASIDONE HCL 40 MG TABLET is a generic product labeled by American Health Packaging, priced at $0.2134 per EA under NDC 60687075821. Its NADAC has been published 160 times since Aug 2, 2023.
FDA first approved this application on Dec 13, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The Low Outlier badge above means this manufacturer's average price in the Lurasidone Hydrochloride market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
40 mg/1
Manufacturer
American Health PackagingNDC
60687075821
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LURASIDONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA212244FDA Approved
12/13/2022
TE Code
AB
On Market Since
7/3/2023
Pharmacological Classes
Price Statistics
The NADAC for LURASIDONE HCL 40 MG TABLET has been published 160 times since Aug 2, 2023, and over the history we have for it it has declined 36.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2134 per EA |
|---|---|
| All-time high | $0.3430 (Jul 10, 2024) |
| All-time low | $0.2002 (Nov 20, 2024) |
| 52-week high | $0.2882 |
| 52-week low | $0.2134 |
| Median price | $0.2893 |
| Average price | $0.2821 |
| Largest weekly change | -34.9% (Nov 20, 2024) |
| Weeks tracked | 160 |
| Tracking since | Aug 2, 2023 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LURASIDONE HCL 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LURASIDONE HCL 40 MG TABLET, manufactured by American Health Packaging, is $0.2134 per EA (NDC 60687075821), effective Aug 19, 2026.
How has the price of LURASIDONE HCL 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for LURASIDONE HCL 40 MG TABLET has declined 36.8%. It has been tracked across 160 weekly CMS publications since Aug 2, 2023.
What are the highest and lowest recorded NADAC prices for LURASIDONE HCL 40 MG TABLET?
Since Aug 2, 2023, the NADAC for LURASIDONE HCL 40 MG TABLET has ranged from a low of $0.2002 (Nov 20, 2024) to a high of $0.3430 (Jul 10, 2024), with a median of $0.2893 per EA.
Are there cheaper alternatives to LURASIDONE HCL 40 MG TABLET?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LURASIDONE HCL 40 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures LURASIDONE HCL 40 MG TABLET?
LURASIDONE HCL 40 MG TABLET (NDC 60687075821) is labeled by American Health Packaging, and CMS classifies it as a generic product.